María Reig

26.1k total citations · 12 hit papers
165 papers, 16.3k citations indexed

About

María Reig is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, María Reig has authored 165 papers receiving a total of 16.3k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Hepatology, 76 papers in Epidemiology and 53 papers in Oncology. Recurrent topics in María Reig's work include Hepatocellular Carcinoma Treatment and Prognosis (120 papers), Liver Disease Diagnosis and Treatment (63 papers) and Hepatitis C virus research (23 papers). María Reig is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (120 papers), Liver Disease Diagnosis and Treatment (63 papers) and Hepatitis C virus research (23 papers). María Reig collaborates with scholars based in Spain, United States and Italy. María Reig's co-authors include Jordi Bruix, Alejandro Forner, Carlos Rodríguez de Lope, Morris Sherman, Carmen Ayuso, Jordi Rimola, Bruno Sangro, Peter R. Galle, Marta Burrel and Ángeles García‐Criado and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

María Reig

151 papers receiving 16.1k citations

Hit Papers

Hepatocellular carcinoma 2010 2026 2015 2020 2018 2021 2016 2010 2016 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hepatocellular carcinoma
    2018 4.1k citations Alejandro Forner, María Reig et al. profile →
  2. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
    2021 2.3k citations María Reig, Alejandro Forner et al. Journal of Hepatology profile →
  3. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
    2016 1.3k citations Jordi Bruix, María Reig et al. profile →
  4. Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
    2010 881 citations Alejandro Forner, María Reig et al. profile →
  5. Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
    2016 725 citations María Reig, Mercedes Iñarrairaegui et al. Journal of Hepatology profile →
  6. Management of HCC
    2012 500 citations Carlos Rodríguez de Lope, Silvia Tremosini et al. Journal of Hepatology profile →
  7. Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
    2016 479 citations Josep M. Llovet, María Reig et al. Journal of Hepatology profile →
  8. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
    2012 365 citations María Reig, Alejandro Forner et al. Journal of Hepatology profile →
  9. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis
    2022 246 citations Amit G. Singal, Nicole E. Rich et al. Journal of Hepatology profile →
  10. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
    2023 147 citations Gonzalo Sapisochín, Alejandro Forner et al. Journal of Hepatology profile →
  11. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
    2024 145 citations Bruno Sangro, Maxime Ronot et al. Journal of Hepatology profile →
  12. CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
    2021 141 citations Ana Matilla, Ignacio Melero et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María Reig Spain 42 11.2k 6.6k 3.3k 3.1k 3.0k 165 16.3k
Tim Meyer United Kingdom 55 6.7k 0.6× 4.2k 0.6× 2.2k 0.7× 2.6k 0.8× 4.9k 1.6× 237 13.8k
Sasan Roayaie United States 40 6.4k 0.6× 3.6k 0.6× 2.8k 0.9× 3.0k 1.0× 2.7k 0.9× 88 12.0k
Laura Kulik United States 61 15.9k 1.4× 8.4k 1.3× 2.5k 0.8× 1.9k 0.6× 2.8k 0.9× 149 20.1k
Alejandro Forner Spain 35 17.4k 1.5× 10.1k 1.5× 5.0k 1.5× 4.5k 1.5× 4.5k 1.5× 120 25.1k
Chris Verslype Belgium 51 6.1k 0.5× 3.7k 0.6× 2.1k 0.6× 2.7k 0.9× 7.3k 2.4× 338 15.4k
Robin Kate Kelley United States 51 6.1k 0.5× 3.0k 0.5× 3.5k 1.1× 3.9k 1.3× 6.1k 2.0× 215 15.4k
Shigeki Arii Japan 60 6.5k 0.6× 3.7k 0.6× 3.4k 1.0× 5.4k 1.8× 3.4k 1.1× 307 14.4k
Mengchao Wu China 59 5.2k 0.5× 3.3k 0.5× 3.8k 1.2× 4.8k 1.6× 3.7k 1.2× 312 13.7k
Sheung Tat Fan Hong Kong 79 9.6k 0.9× 5.1k 0.8× 3.5k 1.1× 5.8k 1.9× 5.5k 1.8× 356 20.5k
Arndt Vogel Germany 55 4.6k 0.4× 3.0k 0.5× 1.9k 0.6× 3.0k 1.0× 4.5k 1.5× 384 12.9k

Countries citing papers authored by María Reig

Since Specialization
Citations

This map shows the geographic impact of María Reig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Reig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Reig more than expected).

Fields of papers citing papers by María Reig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Reig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Reig. The network helps show where María Reig may publish in the future.

Co-authorship network of co-authors of María Reig

This figure shows the co-authorship network connecting the top 25 collaborators of María Reig. A scholar is included among the top collaborators of María Reig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Reig. María Reig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanduzzi‐Zamparelli, Marco, Andrés Castaño‐García, Neus Llarch, et al.. (2025). Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes. European Journal of Cancer. 221. 115404–115404.
2.
Matilla, Ana, Marı́a Varela, Mercedes Iñarrairaegui, et al.. (2025). Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial. Journal of Patient-Reported Outcomes. 9(1). 39–39.
3.
4.
Cabibbo, Giuseppe, Ciro Celsa, Marco Enea, et al.. (2024). Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death. Clinical Cancer Research. 31(3). 543–550. 6 indexed citations
5.
Melero, Ignacio, Maria J. de Miguel, Guillermo de Velasco, et al.. (2024). Effects of neutralization of tumor-derived immunosuppressant GDF-15 on anti-PD-1 activity in anti-PD-(L)1 relapsed/refractory non-squamous NSCLC, urothelial, and hepatocellular cancer.. Journal of Clinical Oncology. 42(16_suppl). 2513–2513. 2 indexed citations
6.
Ferrer, Joana, Berta Caballol, Marco Sanduzzi‐Zamparelli, et al.. (2024). Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection. Journal of Hepatology. 81(6). 995–1004. 23 indexed citations
7.
Tutusaus, Anna, Marco Sanduzzi‐Zamparelli, Loreto Boix, et al.. (2024). Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma. Cancers. 16(8). 1491–1491. 4 indexed citations
8.
Claasen, Marco P. A. W., Dimitri Sneiders, René Adam, et al.. (2023). European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma. Transplant International. 36. 11648–11648. 14 indexed citations
9.
Singal, Amit G., Marco Sanduzzi‐Zamparelli, Pierre Nahon, et al.. (2023). International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance. Journal of Hepatology. 79(1). 226–239. 51 indexed citations
10.
Herranz, José M., María Elizalde, Juan P. Unfried, et al.. (2022). DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis. Cancers. 14(9). 2048–2048. 6 indexed citations
11.
Forner, Alejandro, Jordi Rimola, Anna Darnell, et al.. (2022). Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MR. Radiology and Oncology. 56(3). 292–302. 1 indexed citations
12.
Wege, Henning, Kornelius Schulze, Johann von Felden, Julien Caldéraro, & María Reig. (2021). Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas. European Journal of Medical Genetics. 64(11). 104313–104313. 19 indexed citations
13.
Cucarull, Blanca, Anna Tutusaus, Pablo Garcı́a de Frutos, et al.. (2021). Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species. Antioxidants. 10(9). 1336–1336. 17 indexed citations
14.
Cabibbo, Giuseppe, Ciro Celsa, Marco Enea, et al.. (2020). Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma. Cancers. 13(1). 90–90. 20 indexed citations
15.
Cucarull, Blanca, Anna Tutusaus, Milica Stefanović, et al.. (2020). Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models. Cancers. 12(2). 332–332. 22 indexed citations
16.
Berzigotti, Annalisa, María Reig, Juan G. Abraldeṣ, Jaime Bosch, & Jordi Bruix. (2014). Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysis. Hepatology. 61(2). 526–536. 266 indexed citations
17.
18.
Tremosini, Silvia, Alejandro Forner, Loreto Boix, et al.. (2011). 1016 DIAGNOSIS OF HEPATOCELLULAR CARCINOMA (HCC) ≤2 CM: PROSPECTIVE VALIDATION OF GLYPICAN 3, HEAT-SHOCK PROTEIN 70 AND GLUTAMINE SYNTHETASE S TAINING IN BIOPSY SAMPLES. Journal of Hepatology. 54. S404–S404. 1 indexed citations
19.
Vilana, R., Alejandro Forner, Luís Bianchi, et al.. (2010). Intrahepatic Peripheral Cholangiocarcinoma in Cirrhosis Patients May Display A Vascular Pattern Similar to Hepatocellular Carcinoma on Contrast-Enhanced Ultrasound. Hepatology. 51(6). 2020–2029. 222 indexed citations
20.
Reig, María, Alejandro Forner, Jordi Rimola, et al.. (2009). 815 SORAFENIB FOR THE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA. FEASIBILITY AND SAFETY OUTSIDE RESEARCH TRIALS. Journal of Hepatology. 50. S298–S298. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim Meyer Breakdown of academic impact, for papers by Sasan Roayaie Breakdown of academic impact, for papers by Laura Kulik Breakdown of academic impact, for papers by Alejandro Forner Breakdown of academic impact, for papers by Chris Verslype Breakdown of academic impact, for papers by Robin Kate Kelley Breakdown of academic impact, for papers by Shigeki Arii Breakdown of academic impact, for papers by Mengchao Wu Breakdown of academic impact, for papers by Sheung Tat Fan Breakdown of academic impact, for papers by Arndt Vogel
Rankless by CCL
2026